Unknown

Dataset Information

0

A RET::GRB2 fusion in pheochromocytoma defies the classic paradigm of RET oncogenic fusions.


ABSTRACT: The RET kinase receptor is a target of mutations in neural crest tumors, including pheochromocytomas, and of oncogenic fusions in epithelial cancers. We report a RET::GRB2 fusion in a pheochromocytoma in which RET, functioning as the upstream partner, retains its kinase domain but loses critical C-terminal motifs and is fused to GRB2, a physiological RET interacting protein. RET::GRB2 is an oncogenic driver that leads to constitutive, ligand-independent RET signaling; has transforming capability dependent on RET catalytic function; and is sensitive to RET inhibitors. These observations highlight a new driver event in pheochromocytomas potentially amenable for RET-driven therapy.

SUBMITTER: Estrada-Zuniga CM 

PROVIDER: S-EPMC9381411 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications


The RET kinase receptor is a target of mutations in neural crest tumors, including pheochromocytomas, and of oncogenic fusions in epithelial cancers. We report a RET::GRB2 fusion in a pheochromocytoma in which RET, functioning as the upstream partner, retains its kinase domain but loses critical C-terminal motifs and is fused to GRB2, a physiological RET interacting protein. RET::GRB2 is an oncogenic driver that leads to constitutive, ligand-independent RET signaling; has transforming capability  ...[more]

Similar Datasets

| S-EPMC9989603 | biostudies-literature
2020-01-16 | PXD013461 | Pride
| S-EPMC6430196 | biostudies-literature
| S-EPMC10410168 | biostudies-literature
| S-EPMC5858711 | biostudies-literature
| S-EPMC5924991 | biostudies-literature
| S-EPMC4491180 | biostudies-literature
| S-EPMC7815361 | biostudies-literature
| S-EPMC9441062 | biostudies-literature
| S-EPMC4745701 | biostudies-literature